Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login



UK government rejects recommendations to tackle drug misuse in Scotland

The government rejected calls to declare a public health emergency over drug misuse, and to transfer responsibility for drugs policy to the Department of Health and Social Care.

drug misuse


The UK government said it has no plans to decriminalise drug possession

The UK government has rejected several recommendations put forward by the House of Commons Scottish Affairs Committee (SAC), which had said that “a new approach” was needed to tackle problem drug use.

The government rejected the SAC’s calls to declare a public health emergency over drug misuse, and to transfer lead responsibility for drugs policy from the Home Office to the Department of Health and Social Care. The latter was also a recommendation made by the House of Commons Health and Social Care Committee in October 2019.

The UK government also said it has no plans to decriminalise drug possession. In its report Problem drug use in Scotland, published in November 2019, the SAC had recommended decriminalisation of possession of small amounts of drugs for personal use.

Responding to a recommendation that the UK government “brings forward the legislation necessary to allow for the lawful establishment of a pilot safe consumption facility in Scotland”, the UK government said that primary legislation would be required “to provide complete security to those operating DCRs [drug consumption rooms], which would take a great deal of time to develop and implement”.

However, the UK government did agree in principle with the SAC’s call for the underlying causes of drug misuse — including social inequality — to be acknowledged in approaches to the problem, and for the governments to work together in a cross-departmental approach that engages with health services and third-sector organisations. 

In its response the UK government said it was “already taking action to tackle problem drug use and our approach continues to be a balanced one which is anchored in: education to reduce demand; tough and intelligent enforcement to restrict supply; evidence-based treatment to aid recovery; and co-ordinated global action”.

However, it acknowledged that “there is more that we can and should do”, noting that, following the publication of Dame Carol Black’s Review of Drugs, work was now under way to do more to tackle supply. Dame Carol has, it added, “been commissioned to undertake a review of prevention, treatment and recovery in order to inform further action in those areas”.

Catriona Matheson — chair of Scotland’s Drug Deaths Taskforce, but speaking in a personal capacity, and not for the Taskforce — told The Pharmaceutical Journal that she was “disappointed in the rejection of what was an evidence-based and widely consultative report and recommendations.

“The SAC report looked at international evidence, consulted with people in Scotland and prepared a measured, sensible and pragmatic set of recommendations to address the very real problems we face. The UK government is out of touch in their continued approach to address drugs from a criminal justice angle. The data demonstrates this is not working.”

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2020.20208344

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.